- JP-listed companies
- SymBio Pharmaceuticals Limited
- Balance sheet
SymBio Pharmaceuticals Limited【JP:4582】Balance sheet
Market cap
¥7B
P/E ratio
-2x
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Cash and cash equivalents | - | 5,692 | 4,261 | 5,719 | 2,947 | 4,821 | 3,911 | 3,849 | 3,860 | 6,283 | 6,517 | 3,964 | 2,884 |
| Marketable securities, current | - | 899 | - | - | - | - | - | - | - | - | - | - | - |
| Total cash & short-term investments | - | 6,591 | 4,261 | 5,719 | 2,947 | 4,821 | 3,911 | 3,849 | 3,860 | 6,283 | 6,517 | 3,964 | 2,884 |
| Inventories | - | 245 | 133 | 273 | 363 | 534 | - | 944 | 125 | 294 | 232 | 115 | 153 |
| Total current assets | - | 7,290 | 4,827 | 6,685 | 4,037 | 6,038 | 4,887 | 5,815 | 6,748 | 9,313 | 8,083 | 4,924 | 3,824 |
| Property, plant and equipment, net | - | 49 | 53 | 75 | 47 | 57 | 75 | 77 | 84 | 69 | - | - | - |
| Total non-current assets | - | 164 | 158 | 193 | 216 | 201 | 386 | 459 | 1,705 | 1,121 | 88 | 44 | 43 |
| Total assets | - | 7,454 | 4,984 | 6,878 | 4,252 | 6,239 | 5,274 | 6,275 | 8,453 | 10,433 | 8,170 | 4,968 | 3,867 |
| Total current liabilities | - | 488 | 551 | 942 | 1,011 | 1,336 | 872 | 1,615 | 1,518 | 1,924 | 957 | 766 | 1,290 |
| Total non-current liabilities | - | 2 | 2 | 451 | 1 | 1 | 2 | 2 | 189 | 3 | 4 | 5 | 1,305 |
| Total liabilities | - | 490 | 552 | 1,394 | 1,013 | 1,338 | 874 | 1,617 | 1,707 | 1,927 | 960 | 771 | 2,595 |
| Retained earnings | - | -9,868 | -12,500 | -14,813 | -18,791 | -21,543 | -25,919 | -30,010 | -27,978 | -26,889 | -28,852 | -32,686 | -37,462 |
| Stockholders' equity | 7,433 | 6,964 | 4,432 | 5,485 | 3,239 | 4,902 | 4,400 | 4,657 | 6,746 | 8,506 | 7,210 | 4,198 | 1,272 |